Literature DB >> 12850301

Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies.

Kiyotaka Hitomi1, Richard B Presland, Tomomi Nakayama, Philip Fleckman, Beverly A Dale, Masatoshi Maki.   

Abstract

BACKGROUND: Epidermal-type transglutaminase (TGase 3) is involved in the cross-linking of structural proteins in the epidermis, which results in the formation of the cornified envelope. TGase 3 is activated by limited proteolysis of a 77 kDa zymogen during keratinocyte differentiation.
OBJECTIVE: To characterize the expression of TGase 3 in human epidermis and cultured keratinocytes, we established specific monoclonal antibodies against the TGase 3.
METHODS: Recombinant proteins for human TGase 3 produced in bacteria and baculovirus-infected insect cells were purified as an antigen. Hybridomas are established and used for characterization of expression in epidermis and keratinocytes.
RESULTS: Four antibodies were generated against recombinant human TGase 3, which reacted with the 77 kDa zymogen and in some cases either the 47 or 30 kDa active proteolytic fragments. In human epidermis and cultured keratinocytes, only the zymogen form of TGase 3 was detected. Immunohistochemical analysis of the skin revealed that the enzyme is present in the cells of the granular and cornified layers consistent with its role in cornified envelope formation. In cultured keratinocytes, TGase 3 was expressed in differentiating cells coincident with profilaggrin and keratin 10 expressions.
CONCLUSION: Using monoclonal antibody against human TGase 3, we showed the expression of TGase 3 in upper layers of epidermis. TGase 3 displayed a diffuse cytoplasmic distribution in vitro consistent with its proposed role in the early phase of cornified cell envelope assembly in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850301     DOI: 10.1016/s0923-1811(03)00091-4

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  10 in total

1.  Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells.

Authors:  Sasha Tharakan; Luca Pontiggia; Thomas Biedermann; Sophie Böttcher-Haberzeth; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2010-01       Impact factor: 1.827

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

3.  Optimization of filaggrin expression and processing in cultured rat keratinocytes.

Authors:  Sudeshna M Chatterjea; Katheryn A Resing; William Old; Wilas Nirunsuksiri; Philip Fleckman
Journal:  J Dermatol Sci       Date:  2010-11-13       Impact factor: 4.563

4.  The mouse wellhaarig (we) mutations result from defects in epidermal-type transglutaminase 3 (Tgm3).

Authors:  Brett M Brennan; Minh T Huynh; Mohammed A Rabah; Hailie E Shaw; Jason J Bisaillon; Legairre A Radden; Tu V Nguyen; Thomas R King
Journal:  Mol Genet Metab       Date:  2015-07-15       Impact factor: 4.797

5.  Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis.

Authors:  Themis R Kyriakides; Drausin Wulsin; Eleni A Skokos; Philip Fleckman; Annalisa Pirrone; J Michael Shipley; Robert M Senior; Paul Bornstein
Journal:  Matrix Biol       Date:  2009-01-20       Impact factor: 11.583

6.  Examination of oral cancer biomarkers by tissue microarray analysis.

Authors:  Peter Choi; C Diana Jordan; Eduardo Mendez; John Houck; Bevan Yueh; D Gregory Farwell; Neal Futran; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

7.  Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.

Authors:  Seema Nayak; M L B Bhatt; Madhu Mati Goel; Seema Gupta; Abbas Ali Mahdi; Anupam Mishra; Divya Mehrotra
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

8.  Ectopic transglutaminase 1 and 3 expression accelerating keratinization in oral lichen planus.

Authors:  Katsumitsu Shimada; Takanaga Ochiai; Hiromasa Hasegawa
Journal:  J Int Med Res       Date:  2018-09-13       Impact factor: 1.671

9.  TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.

Authors:  Xiangbing Wu; Wei Cao; Xu Wang; Jianjun Zhang; Zhongjing Lv; Xing Qin; Yadi Wu; Wantao Chen
Journal:  Mol Cancer       Date:  2013-12-01       Impact factor: 27.401

Review 10.  Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer.

Authors:  Elina S Chermnykh; Elena V Alpeeva; Ekaterina A Vorotelyak
Journal:  Cells       Date:  2020-08-30       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.